2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ARV-110: new trials by email Literature Review of ARV-110 trials Research Report on ARV-110
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer Bavdegalutamide, Abiraterone - Prostate Cancer Metastatic | Phase 1 | Completed | Arvinas Androgen Receptor, Inc. | 45 | 2022-05-13 | 2026-04-28 |
| Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer ARV-110 - Prostate Cancer Metastatic | Phase 1 / Phase 2 | Completed | Arvinas Inc. | 248 | 2019-03-01 | 2025-04-01 |
Arvinas Androgen Receptor, Inc. (1) · Arvinas Inc. (1)
United States (2) · Canada (1) · France (1) · United Kingdom (1)